Major aortopulmonary collateral arteries: A cause of difficult weaning from extracorporeal membrane oxygenator after arterial switch operation Authors: Periyasamy Sathesh Kumar, Palaniraj Suresh, Vimlendra Kumar Choudhary, Shrinivas Vitthal Gadhinglajkar, Baiju S. Dharan Published: 2026 Dear Sir, Extracorporeal membrane oxygenator (ECMO) may be required in infants after arterial switch operation (ASO) due to of regressed left ventricle (LV) or temporary myocardial dysfunction.[12] Weaning from the ECMO may be difficult due to persistent myocardial dysfunction or valvular regurgitation. We present a rare case scenario, wherein overlooked major aortopulmonary collateral arteries (MAPCAs) were associated with failure to wean the patient from the ECMO. A 4-month-old male infant with d-transposition of the great arteries (d-TGA), intact ventricular septum, and a regressed LV underwent an ASO. After weaning the patient from cardiopulmonary bypass (CPB) with levosimendan and vasopressin infusion, the LV appeared dilated. However, systolic function was fair, mitral regurgitation was mild, and left atrial pressure (LAP) was in the range of 10–15 mmHg. Sternum was left open anticipating further worsening of LV function. Postoperatively, within 1 h of shifting to intensive care unit, he developed sudden hypotension and cardiac arrest, requiring open-chest resuscitation and establishment of a central venoarterial ECMO. Despite apparent myocardial recovery on epicardial echocardiography, minimum vaso-inotropic support, and normal serum lactate levels, multiple attempts of weaning from ECMO failed due to progressive left heart distension and increased LAP (16–18 mmHg). Epicardial echocardiography revealed moderate LV dysfunction but no significant mitral regurgitation or residual lesions. LA decompression was done via cannulation, but high LAP and LV distension persisted. Retrospective analysis of preoperative transthoracic echocardiography revealed suspicious MAPCAs which were not given consideration during the surgery [Figure 1]. Given the unexplained pulmonary venous hypertension and LA hypertension, surgical reexploration was undertaken on postoperative day 4, while the patient remained on ECMO support. Two moderate-sized MAPCAs arising from the aortic arch and descending thoracic aorta were identified and ligated [Figure 2]. Following this, the patient was successfully weaned from ECMO on postoperative day 6 and had an uneventful recovery. Retrospective visualization of major aortopulmonary collateral arteries from aortic arch on preoperative transthoracic echocardiography in suprasternal aortic arch view. MAPCA: Major aortopulmonary collateral artery Schematic diagram showing two major aortopulmonary collateral arteries from aortic arch and descending thoracic aorta. MAPCA: Major aortopulmonary collateral artery, DTA: Descending thoracic aorta MAPCAs causing elevation in the LAP and impeding weaning from the ECMO support is an uncommon condition. MAPCAs are rare in patients with d-TGA, with an estimated prevalence of approximately 2%, mostly in those with lower oxygen saturations.[3] These vessels are believed to persist in congenital heart lesions associated with decreased pulmonary blood flow, such as pulmonary atresia with ventricular septal defect.[45] While uncommon in patients with d-TGA,[6] this case highlights the need to consider MAPCAs as the reversible cause of elevated LAP, distended LV, and failed weaning from ECMO/CPB. When established causes such as ventricular dysfunction, mitral regurgitation, or residual shunts are excluded, persistent pulmonary over circulation due to the MAPCAs should be suspected. In our case, the presence of MAPCAs preserved the LV thickness even at the age of 4 months. Awareness of this rare entity is essential for prompt diagnosis and timely surgical intervention or catheter-based coiling, which can avoid untoward postoperative events. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest.